Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gordon Robertson

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
NPJ Breast Cancer|July 20, 2017
DNA defects, epigenetics, and gene expression in cancer-adjacent breast: a study from The Cancer Genome AtlasMelissa A Troester, Katherine A Hoadley, Monica D'Arcy, et al.
Cell Reports. Medicine|January 14, 2022
Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insightCarolyn D Hurst, Guo Cheng, Fiona M Platt, et al.
Genome Medicine|October 18, 2019
Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosisJoep J de Jong, Yang Liu, A Gordon Robertson, et al.
Cell|April 7, 2018
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of CancerKatherine A Hoadley, Christina Yau, Toshinori Hinoue, et al.
Cancer Cell|February 7, 2017
Comprehensive Molecular Characterization of Pheochromocytoma and ParagangliomaLauren Fishbein, Ignaty Leshchiner, Vonn Walter, et al.
Nature Medicine|May 3, 2014
A new transcriptional role for matrix metalloproteinase-12 in antiviral immunityDavid J Marchant, Caroline L Bellac, Theo J Moraes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2019
Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck CancerAnthony D Saleh, Hui Cheng, Scott E Martin, et al.
Oncogene|April 24, 2023
The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responsesZhiping Li, Xuanmao Jiao, A Gordon Robertson, et al.
Research Square|January 30, 2023
The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responsesZhiping Li, Xuanmao Jiao, A Gordon Robertson, et al.
Science (New York, N.Y.)|October 27, 2018
The chromatin accessibility landscape of primary human cancersM Ryan Corces, Jeffrey M Granja, Shadi Shams, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
NPJ Breast Cancer|July 20, 2017
DNA defects, epigenetics, and gene expression in cancer-adjacent breast: a study from The Cancer Genome AtlasMelissa A Troester, Katherine A Hoadley, Monica D'Arcy, et al.
Cell Reports. Medicine|January 14, 2022
Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insightCarolyn D Hurst, Guo Cheng, Fiona M Platt, et al.
Genome Medicine|October 18, 2019
Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosisJoep J de Jong, Yang Liu, A Gordon Robertson, et al.
Cell|April 7, 2018
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of CancerKatherine A Hoadley, Christina Yau, Toshinori Hinoue, et al.
Cancer Cell|February 7, 2017
Comprehensive Molecular Characterization of Pheochromocytoma and ParagangliomaLauren Fishbein, Ignaty Leshchiner, Vonn Walter, et al.
Nature Medicine|May 3, 2014
A new transcriptional role for matrix metalloproteinase-12 in antiviral immunityDavid J Marchant, Caroline L Bellac, Theo J Moraes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2019
Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck CancerAnthony D Saleh, Hui Cheng, Scott E Martin, et al.
Oncogene|April 24, 2023
The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responsesZhiping Li, Xuanmao Jiao, A Gordon Robertson, et al.
Research Square|January 30, 2023
The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responsesZhiping Li, Xuanmao Jiao, A Gordon Robertson, et al.
Science (New York, N.Y.)|October 27, 2018
The chromatin accessibility landscape of primary human cancersM Ryan Corces, Jeffrey M Granja, Shadi Shams, et al.
Pageof 8